MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
MINNEAPOLIS, July 19, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Inspire Medical Systems, Inc. (N
The recall of Inspire Medical 's (INSP) Inspire IV Implantable Pulse Generators might dampen the company's future sales.
The FDA has labeled a recall of Inspire Medical Systems, Inc.'s INSP nerve-stimulating implant for obstructive sleep apnea as Class I, the most serious kind.
MINNEAPOLIS, July 02, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the second quarter 2024 after the close of trading on Tuesday, Au
Inspire (INSP) reported earnings 30 days ago. What's next for the stock?
MINNEAPOLIS, June 04, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minima
Buying the dips and acquiring shares of a proven company on short-term declines has been a successful strategy over the long-term. When investors look back five or 10 years from now, the opportunities
MINNEAPOLIS, May 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimal
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
Inspire (INSP) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates c
Inspire Medical's (INSP) both geographic segments witness strong revenue growth in the first quarter.
While the top- and bottom-line numbers for Inspire (INSP) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare t
Inspire Medical Systems, Inc. (NYSE:INSP ) Q1 2024 Results Conference Call May 7, 2024 5:00 PM ET Company Participants Ezgi Yagci - VP, IR Tim Herbert - Chairman and CEO Rick Buchholz - CFO Conference
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE